ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $69,952,000 | +42.6% | 406,459 | +4.0% | 0.02% | +43.8% |
| Q2 2021 | $49,063,000 | -5.1% | 390,966 | +2.5% | 0.02% | -15.8% |
| Q1 2021 | $51,709,000 | +10.0% | 381,306 | +3.8% | 0.02% | 0.0% |
| Q4 2020 | $46,991,000 | +15.5% | 367,289 | +1.6% | 0.02% | 0.0% |
| Q3 2020 | $40,681,000 | +77.3% | 361,509 | +50.1% | 0.02% | +72.7% |
| Q2 2020 | $22,940,000 | -12.8% | 240,786 | -17.7% | 0.01% | -26.7% |
| Q1 2020 | $26,297,000 | +71.9% | 292,603 | +1.4% | 0.02% | +87.5% |
| Q4 2019 | $15,299,000 | +37.5% | 288,539 | +2.4% | 0.01% | +14.3% |
| Q3 2019 | $11,129,000 | +3.3% | 281,652 | +7.4% | 0.01% | 0.0% |
| Q2 2019 | $10,778,000 | -6.2% | 262,346 | +6.4% | 0.01% | 0.0% |
| Q1 2019 | $11,486,000 | +24.1% | 246,638 | +16.1% | 0.01% | 0.0% |
| Q4 2018 | $9,253,000 | -24.3% | 212,456 | -0.5% | 0.01% | -12.5% |
| Q3 2018 | $12,219,000 | +22.7% | 213,497 | +4.0% | 0.01% | +14.3% |
| Q2 2018 | $9,959,000 | +32.5% | 205,240 | +6.7% | 0.01% | +16.7% |
| Q1 2018 | $7,518,000 | +0.9% | 192,271 | +9.5% | 0.01% | 0.0% |
| Q4 2017 | $7,451,000 | +26.4% | 175,553 | +11.1% | 0.01% | +20.0% |
| Q3 2017 | $5,895,000 | +34.8% | 157,952 | +9.8% | 0.01% | +25.0% |
| Q2 2017 | $4,372,000 | +25.3% | 143,842 | +9.1% | 0.00% | +33.3% |
| Q1 2017 | $3,490,000 | +9.8% | 131,841 | +5.9% | 0.00% | 0.0% |
| Q4 2016 | $3,178,000 | -25.5% | 124,506 | +5.7% | 0.00% | -40.0% |
| Q3 2016 | $4,264,000 | +12.0% | 117,797 | +5.1% | 0.01% | 0.0% |
| Q2 2016 | $3,808,000 | +35.6% | 112,057 | +5.3% | 0.01% | +25.0% |
| Q1 2016 | $2,809,000 | -36.9% | 106,423 | +16.5% | 0.00% | -33.3% |
| Q4 2015 | $4,454,000 | +135.0% | 91,329 | +20.0% | 0.01% | +100.0% |
| Q3 2015 | $1,895,000 | +30.0% | 76,092 | +65.2% | 0.00% | +50.0% |
| Q2 2015 | $1,458,000 | -2.4% | 46,055 | +17.4% | 0.00% | 0.0% |
| Q1 2015 | $1,494,000 | +1.4% | 39,237 | +3.8% | 0.00% | 0.0% |
| Q4 2014 | $1,473,000 | +65.9% | 37,800 | +28.8% | 0.00% | +100.0% |
| Q3 2014 | $888,000 | -10.0% | 29,345 | +1.1% | 0.00% | -50.0% |
| Q2 2014 | $987,000 | +66.7% | 29,039 | +69.5% | 0.00% | +100.0% |
| Q1 2014 | $592,000 | +6.9% | 17,135 | +22.6% | 0.00% | 0.0% |
| Q4 2013 | $554,000 | – | 13,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |